Latest Novo Nordisk News & Updates

See the latest news and media coverage for Novo Nordisk. We track all announcements, press releases, and industry mentions in real time, all in one place.

Novo Nordisk

Global pharmaceutical company developing treatments for chronic diseases

novonordisk.com

Headquarters: Bagsværd, Denmark
Founded year: 1923
Company type: Public company
Number of employees: 60,000+
Industry: Pharmaceuticals

Last updated Today

Latest news about Novo Nordisk

In short: Novo Nordisk raised its 2026 outlook despite the Phase 3 failure of its cardiovascular drug ziltivekimab and resulting stock pressure.

Company announcements

August 10 Novo Nordisk

Novo Nordisk partners with AWS to accelerate AI drug discovery

The collaboration establishes a London innovation hub and designates AWS as the primary cloud provider, aiming to compress clinical trial timelines and improve operational productivity.

August 5 Novo Nordisk

Novo Nordisk wins Dutch court injunction on semaglutide spray

The District Court of The Hague ordered Ceban to stop selling the infringing product and reimburse legal costs.

August 4 Novo Nordisk

Novo Nordisk raises adjusted sales and operating profit outlook

Q2 adjusted sales grew 7% and adjusted operating profit grew 11% at CER, prompting the improved full-year guidance.

August 4 Novo Nordisk

Novo Nordisk reports updates on its share repurchase programme

Recent transactions added 13.1 million shares at roughly DKK 3.98 billion to the fund, raising total treasury holdings to 0.9% of issued capital.

Media coverage

Yesterday MSN

FDA: Novo Nordisk failed to report deaths of weight-loss drug patients

Novo Nordisk's reports to the FDA spiked shortly after an inspection found the Ozempic producer ignored reports of deaths and ...

Yesterday Yahoo Finance

NVO Stock: Why Morgan Stanley Is Bearish On Novo Nordisk Despite Its Weight-Loss Drug Opportunity

Morgan Stanley downgraded Novo to ‘Underweight’ from ‘Equal Weight’ while keeping its $40 price targ...

September 10 BankInfoSecurity

Novo Nordisk Data Breach Tied to Stolen GitHub Access Tokens

Cyber extortion group FulcrumSec continues to find hardcoded credentials in public-facing IT infrastructure and exploit them as part of what it's dubbed a...

September 10 Affärsvärlden

Wegovy approved in China for MASH treatment

Novo Nordisk announced that the plant-based GLP-1 medicine Wegovy has received approval in China for the treatment of MASH.

Never miss news about Novo Nordisk

Track Novo Nordisk and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Novo Nordisk competitors & trending companies

Browse news for competitors to Novo Nordisk and other trending companies.